Literature DB >> 16387392

Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs.

Zhi-yun Du1, Rong-rong Liu, Wei-yan Shao, Xue-pu Mao, Lin Ma, Lian-quan Gu, Zhi-shu Huang, Albert S C Chan.   

Abstract

Natural curcumin (1), demethoxycurcumin (2) and bisdemethoxycurcumin (3) isolated from Curcuma longa (turmeric), and synthetic curcumin analogs (A(1-7), B(1-7), C(1-6) and D(1-7)) were evaluated in vitro for the alpha-glucosidase inhibitory activity via UV and circular dichroism (CD) spectroscopy. The results indicated that natural curcuminoid compound 3 showed a remarkable inhibitory effect with IC(50) of 23.0 microM, and the synthetic compounds A(2), B(2), C(2) and D(2) showed potent inhibitory effects with IC(50) of 2.8, 2.6, 1.6 and 8.2 microM, respectively. Kinetic study exhibited that the mechanism of alpha-glucosidase inhibition of both 3 and C(2) was non-competitive. The structure activity relationship revealed that the ortho dihydroxyl groups could form a more tight interaction with alpha-glucosidase to exert more potential inhibitory activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16387392     DOI: 10.1016/j.ejmech.2005.10.012

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  27 in total

1.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

2.  Structure Activity Related, Mechanistic, and Modeling Studies of Gallotannins containing a Glucitol-Core and α-Glucosidase.

Authors:  Hang Ma; Ling Wang; Daniel B Niesen; Ang Cai; Bongsup P Cho; Wen Tan; Qiong Gu; Jun Xu; Navindra P Seeram
Journal:  RSC Adv       Date:  2015-12-14       Impact factor: 3.361

3.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

Review 4.  Antidiabetic Properties of Curcumin: Insights on New Mechanisms.

Authors:  Elahe Mohammadi; Behzad Behnam; Reza Mohammadinejad; Paul C Guest; Luis E Simental-Mendía; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.

Authors:  Lauren Friedman; Li Lin; Sarah Ball; Tanios Bekaii-Saab; James Fuchs; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  Anticancer Drugs       Date:  2009-07       Impact factor: 2.248

6.  Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats.

Authors:  Bandugula Venkata Reddy; Jayakumar Sivagama Sundari; Elumalai Balamurugan; Venugopal Padmanabhan Menon
Journal:  Mol Cell Biochem       Date:  2009-05-26       Impact factor: 3.396

7.  The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes.

Authors:  Fatemeh Hasaninezhad; Zohreh Tavaf; Farhad Panahi; Maryam Nourisefat; Ali Khalafi-Nezhad; Reza Yousefi
Journal:  J Diabetes Metab Disord       Date:  2020-11-12

8.  (3E,5E)-3,5-Bis(4-hy-droxy-3,5-di-methoxy-benzyl-idene)oxan-4-one monohydrate.

Authors:  Zhi-Yun Du; Hua-Rong Huang; Yu-Jun Lu; Kun Zhang; Yan-Xiong Fang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

9.  (3E,5E)-3,5-Bis(4-hy-droxy-benzyl-idene)oxan-4-one.

Authors:  Zhi-Yun Du; Hua-Rong Huang; Yu-Jun Lu; Kun Zhang; Yan-Xiong Fang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-11

10.  Synthesis of new curcumin-based aminocarbonitrile derivatives incorporating 4H-pyran and 1,4-dihydropyridine heterocycles.

Authors:  Soheila Khajeh Dangolani; Farhad Panahi; Ali Khalafi-Nezhad
Journal:  Mol Divers       Date:  2020-05-17       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.